[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-334717-105":59,"doc-detail-334717-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","evaluation-of-the-anticancer-effects-exerted-by-5-fluorouracil-and-heme-oxygenase-1-inhibitor-hybrids-in-htc116-colorectal-cancer-cells","Evaluation of the anticancer effects exerted by 5-fluorouracil and heme oxygenase-1 inhibitor hybrids in HTC116 colorectal cancer cells","","Colon cancer remains a clinical challenge, and 5-fluorouracil (5-FU) therapy is limited by side effects and resistance. Heme oxygenase-1 (HO-1) is an emerging anticancer target. This study evaluates HO-1 inhibitor hybrid compounds with 5-FU in HCT116 colorectal cancer cells, showing that SI1/22 and the corresponding combination are more potent than 5-FU. Hybrids inhibit HO-1 activity, elevate ROS and HO-1/SOD/Nrf2 expression, and shift apoptosis/autophagy markers toward cleaved PARP-1 and increased p62. ",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/evaluation-of-the-anticancer-effects-exerted-by-5-fluorouracil-and-heme-oxygenase-1-inhibitor-hybrids-in-htc116-colorectal-cancer-cells/334717/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/evaluation-of-the-anticancer-effects-exerted-by-5-fluorouracil-and-heme-oxygenase-1-inhibitor-hybrids-in-htc116-colorectal-cancer-cells/334717.png","ImageObject",300,407,{"name":92,"@type":93},"Ava Thompson","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-03","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"How do the 5-FU/HO-1 hybrid compounds compare to 5-FU in HCT116 cells?","Question",{"text":112,"@type":113},"SI1/22 and the corresponding combination show greater potency than 5-FU in the HCT116 colorectal cancer cell model.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What cellular mechanisms are associated with the hybrids’ anticancer activity?",{"text":117,"@type":113},"The hybrids inhibit HO-1 activity in cell lysates, increase ROS, and enhance the expression of HO-1, SOD, and Nrf2.",{"name":119,"@type":110,"acceptedAnswer":120},"Do the hybrids influence apoptosis and autophagy markers?",{"text":121,"@type":113},"Yes. The study reports a decrease in pro-caspase and an increase in cleaved PARP-1 and p62, consistent with apoptotic and autophagic cell death.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},334717,1790088225,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":44,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":4},1649267921044,"https://us-avatar.wpscdn.com/avatar/1800007509477c92dfb?_k=1786009248482753345","Evaluation of the anticancer effects exerted by 5-fluorouracil and heme oxygenase-1 inhibitor hybrids in HTC116 colorectal cancer cells  \nLoredana Salernoa*, Antonietta Notarob*, Valeria Consolia, Federica Affranchib, Valeria Pittalàa,c, Valeria Sorrentia, Luca Vanellaa, Michela Giulianob and Sebastiano Intagliataa  \nadepartment of drug and health sciences, university of catania, catania, Italy; bdepartment of biological, chemical and Pharmaceutical sciences and technologies (stEbIcEf), university of Palermo, Palermo, Italy; cdepartment of molecular medicine, arabian Gulf university, manama, bahrain  \nABSTRACT  \nColon cancer remains a clinical challenge in industrialised countries. Its treatment with 5-Flurouracil (5-FU) develops many side effects and resistance. Thus, several strategies have been undertaken so far, includingthe use of drug cocktails and polypharmacology. Heme oxygenase-1 (HO-1) is an emerging molecular target in the treatment of various cancers. We recently demonstrated that a combination of HO-1 inhibitors with 5-FU and the corresponding hybrids SI1/17, SI1/20, and SI1/22, possessed anticancer activity against prostate and lung cancer cells. In this work, we evaluated these hybrids in a model of colon cancer and found that SI1/22 and the respective combo have greater potency than 5-FU. Particularly, compounds inhibit HO-1 activity in cell lysates, increase ROS and the expression of HO-1, SOD, and Nrf2. Moreover, we observed a decrease of pro-caspase and an increase in cleaved PARP-1 and p62, suggesting apoptotic and autophagic cell death and potential application of these drugs as anticancer agents.  \nARTICLE HISTORY  \nreceived 17 october 2023 revised 17 february 2024 accepted 25 march 2024  \nKEYWORDS  \nhybrids; mutual prodrugs; 5-fluorouracil; heme oxygenase 1; htc116 colorectal cancer cells  \nIntroduction  \nA novel target for anticancer therapy is the HO family of enzymes (HO-1, HO-2, and HO-3) devoted to the catabolism of heme1, and the production of iron, carbon monoxide, biliverdin, and bilirubin2,3. Although HO has mainly a cytoprotective role, overexpression of the inducible isoform HO-1 has been observed in many types of cancers, contributing to cancer spread and invasiveness4; therefore, HO-1 inhibitors have been developed in the last years as new anticancer agents both alone and combined with chemotherapeutic drugs5–9.  \nColorectal cancer (CRC) is the third most common cancer diagnosed, and the second cause of cancer death10. In CRC, HO-1 has been demonstrated to be involved in cancer induction and spreading. Different studies pointed out a remarkable high HO-1 expression and activity in tumour tissue from CRC patients11 and, more specifically, the highest HO-1 expression has been detected in well-differentiated tumour areas of CRC. High nuclear localisation of HO-1 was also shown in human HCT116 cells where it activates transcription factors responsible for protection from oxidative stress and involved in cell proliferation, such as AP-1, AP-2, and Brn-312. CRC is treated with different chemotherapeutic drugs, including 5-fluorouracil (5-FU), capecitabine, irinotecan, oxaliplatin, trifluridine and tipiracil13. Despite the substantial advances achieved in the last years with chemotherapeutic  \nagents against CRC, severe side effects, toxicity, and drug resistance are the major clinical problems14, 15.  \n5-FU is an essential medicine on the WHO list16, belonging to the chemical class of pyrimidine antimetabolites17; it is prescribed as first-line therapy for CRC18, 19. 5-FU exerts its cytotoxic activity through the inhibition of thymidylate synthase and the incorporation of its metabolites into nucleic acids, causing DNA damage; however, this action is not selective against cancer cell20–22. In addition, unfavourable pharmacokinetic (PK) properties negatively contribute to the 5-FU drug profile23. To overcome these limits, 5-FU is often used in combined therapy for the treatment of CRC (e.g. FOLFOX ","cbCail0uGHyTCYZQ","https://ap.wps.com/l/cbCail0uGHyTCYZQ","pdf",3044385,"English","# Introduction\n## HO enzyme family and HO-1 as an anticancer target\n## Colorectal cancer context and current chemotherapy\n## 5-FU limitations and combination strategies\n## Rationale for hybrids and mutual prodrugs\n## Prior synthesis of 5-FU/HO-1 hybrids (SI1/17, SI1/20, SI1/22)","[{\"question\":\"How do the 5-FU/HO-1 hybrid compounds compare to 5-FU in HCT116 cells?\",\"answer\":\"SI1/22 and the corresponding combination show greater potency than 5-FU in the HCT116 colorectal cancer cell model.\"},{\"question\":\"What cellular mechanisms are associated with the hybrids’ anticancer activity?\",\"answer\":\"The hybrids inhibit HO-1 activity in cell lysates, increase ROS, and enhance the expression of HO-1, SOD, and Nrf2.\"},{\"question\":\"Do the hybrids influence apoptosis and autophagy markers?\",\"answer\":\"Yes. The study reports a decrease in pro-caspase and an increase in cleaved PARP-1 and p62, consistent with apoptotic and autophagic cell death.\"}]","Evaluation of the anticancer effects exerted by 5-fluorouracil and heme oxygenase-1 inhibitor hybrids in HTC116 colorectal cancer cells | PDF",1790007998,23]